Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Recent findings with a rhesus monkey cytomegalovirus based simian immunodeficiency virus vaccine have identified strong CD8+ T cell responses that are restricted by MHC-E. Also mycobacteria specific CD8+ T cells, that are MHC-E restricted, have been identified. MHC-E therefore can present a wide range of epitope peptides to CD8+ T cells, alongside its well defined role in presenting a conserved MHC-class I signal peptide to the NKG2A/C-CD94 receptor on natural killer cells. Here we explore the antigen processing pathways involved in these atypical T cell responses.

Original publication

DOI

10.1016/j.coi.2017.04.009

Type

Journal article

Journal

Curr Opin Immunol

Publication Date

06/2017

Volume

46

Pages

75 - 81

Keywords

AIDS Vaccines, Animals, Antigen Presentation, CD8-Positive T-Lymphocytes, Epitopes, T-Lymphocyte, HIV, HIV Antigens, HIV Infections, Histocompatibility Antigens Class I, Host-Pathogen Interactions, Humans, T-Lymphocyte Subsets